Monika Raman, PSG College of Technology, Coimbatore Lung cancer, one of the most common and deadliest cancers, affected 2.2 million people and caused 1.79 million deaths worldwide in 2020. Most of the primary lung cancers are carcinomas. Small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC) are their two main types. About 15% of lung […]
Sayak Banerjee, Amity University Kolkata Scientists have come over a class of drugs utilized in the treatment of breast and ovarian cancer which might be effective in other types of diseases with inadequate treatment alternatives. These are called PARP inhibitors which have the potential to kill cancer cells carrying a defect in the Polybromo 1(PBRM1) […]
Thota Kanishka Rao, Amity University Kolkata Cancer is one of the most dangerous diseases causing the death of millions globally. 1 out of every 6 deaths, around 6,000 people each day. There is no single test that can precisely analyze malignancy. The total evaluation of a patient for the most part requires a thorough history […]
AISHILA KAR, AMITY UNIVERSITY KOLKATA Cancer begins when cells in the body start to grow uncontrollably. The most important utility for the lung was maintaining a stream utilizing oxygen within the whole body. Lung cancer is a single hazardous problem, which might present in small and in the nonsmall cell too. But it is normally […]
-Biswadeep Sen, Amity University Kolkata We all can agree to the fact that despite the advancement in the treatments and technology, Lung Cancer is still, by far, the leading cause of cancer death worldwide. Amongst the multiple oncogenic driver alterations discovered the one with the most frequent aberration is KRAS mutation. To make matters worse, […]
-Biswadeep Sen, Amity University Kolkata Lung cancer has troubled scientists for decades now. But with the passing of each decade, a newer method of its detection and treatment has emerged. Now as we set foot onto the second decade of the 21st century, we are successful in treating selective targets of the NSCLC. Mutant EGFR […]
–Biswadeep Sen, Amity University Kolkata Lung Cancer is one of the most malignant tumors, making patients more susceptible to infections than normal individuals. Lung Cancer patients are susceptible to SARS-CoV-2 infection at a significantly higher rate than healthy individuals. Angiotensin-converting enzyme 2, acting as the COVID receptor, and the Transmembrane protease serine 2 acting as […]
